Looking for tumor cells in blood and spinal fluid in people whose aggressive meningioma has come back
Official title: Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study checks whether cells from an aggressive meningioma can be found in a person's blood or spinal fluid.
Read our full plain-language summary
What the trial team says
The goal of the clinical trial is to assess the presence of circulating tumor cells (CTCs) in the blood and/or cerebrospinal fluid (CSF) of patients with aggressive recurrent meningiomas.
Key facts
- Registry number
- NCT07398170
- Stage of testing
- Not applicable
- Conditions studied
- Meningioma
Where it is running
This trial lists 1 site.
-
France
- CHU de Montpellier (Montpellier)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.